Results 41 to 50 of about 9,989 (122)

Bimekizumab efficacy using IHS4 outcomes in hidradenitis suppurativa: Results from BE HEARD I and II

Journal of the European Academy of Dermatology and Venereology, EarlyView.
The majority of bimekizumab‐treated patients shifted from severe to mild and moderate IHS4 stages, and nearly 25% achieved an IHS4 of 0 by Week 48. Bimekizumab led to clinically meaningful improvements across IHS4 outcome measures. These data highlight an opportunity to address the need for effective treatments against draining tunnels.
Thrasyvoulos Tzellos, Evangelos J. Giamarellos‐Bourboulis, Kelsey R. van Straalen, Antonio Martorell, Brian Kirby, Afsaneh Alavi, Koremasa Hayama, Saakshi Khattri, Wayne Gulliver, Christopher J. Sayed, Leah Davis, Robert L. Rolleri, Christina Crater, Ingrid Pansar, Jérémy Lambert, Christos C. Zouboulis   +15 more
wiley   +1 more source

Budd-Chiari syndrome in association with Behçet's disease: review of the literature

São Paulo Medical Journal
The risk that patients with Behçet's disease may develop various thrombotic complications has been previously described. Although vascular complications from Budd-Chiari syndrome associated with Behçet's disease have been described, the pathogenic ...
Daniela Carvalho, Fernando Oikawa, Nilce Mitiko Matsuda, Alice Tatsuko Yamada   +3 more
doaj   +1 more source

Dermatologic Findings of RELA‐Associated Autoinflammatory Disease

Pediatric Dermatology, EarlyView.
ABSTRACT Variants in the gene RELA have been implicated in a monogenic, hereditary form of Behcet's‐like syndrome. This case series describes the dermatologic manifestations of three patients with identified RELA‐associated autoinflammatory disease.
Elizabeth Nourse, Vidya Sivaraman, Catherine G. Chung, Shoghik Akoghlanian, Esteban Fernandez Faith   +4 more
wiley   +1 more source

Malignant lymphoma associated with Behçet’s disease: A report of 2 cases

Turkish Journal of Hematology, 2011
Herein we report 2 cases of malignant lymphoma associated with Behçet’s disease. Case 1, a 53-year-old man, was diagnosed as Behçet’s disease at the age of 26 years, and was treated with cyclophosphamide and prednisolone.
Ahmet Deniz Meydan, Bilge Gürsel, Nilgün Özbek, Bilge Can, Bilge Can   +4 more
doaj   +3 more sources

Transition From Juvenile Dermatomyositis to Spondyloarthritis: A Novel Overlapping Inflammatory Phenotype

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Juvenile dermatomyositis (JDM) is a rare childhood inflammatory myopathy, whereas spondyloarthritis (SpA) is an inflammatory arthropathy characterized by enthesitis and peripheral or axial involvement. We describe a series of patients diagnosed with JDM in childhood who later fulfilled classification criteria for SpA, a sequential phenotype ...
Austen Grooms, Ioannis Karageorgiou, Kerry Mychaliska, James Birmingham   +3 more
wiley   +1 more source

Paradoxical Behçet’s Disease after Ixekizumab: A Case Report and Literature Review

Indian Journal of Dermatology
Behçet’s disease is a chronic inflammatory condition that affects multiple organs and systems. It is characterized by recurrent oral and genital ulcers.
Yue-Kang Ren, Ling Ren, Wen Sun, Hong-Ye Liu, Shu-Ping Guo   +4 more
doaj   +1 more source

A rare involvement in Behcet's Disease: Carotid artery aneurysm

İstanbul Kuzey Klinikleri, 2017
Behçet's disease is an inflammatory disease characterized by recurrent oral aphthous ulcers and various accompanying systemic pathologies. These additional pathologies include ocular and neurologic disease, genital ulcers, skin lesions, arthritis and ...
Hamit Serdar Başbuğ, Yalçın Günerhan, Hakan Göçer, Kanat Özışık   +3 more
doaj   +1 more source

Vitiligo Arising at the Injection Site of Interferon‐α

JEADV Clinical Practice, EarlyView.
Yubin Peng, Tao Wang
wiley   +1 more source

Safety of Immune Checkpoint Inhibitors in Cancer Patients With Preexisting Autoimmune Vasculitis

ACR Open Rheumatology, Volume 8, Issue 3, March 2026.
Objective Immune checkpoint inhibitors (ICIs) are effective cancer therapies but often cause serious immune‐related adverse events (irAEs). Patients with preexisting autoimmune diseases, including vasculitis, are excluded from trials. We aimed to evaluate the frequency, severity, and outcomes of vasculitis flares and irAEs in this population.
Juan Sevillano, Noha Abdel‐Wahab, Yixuan Zhou, Juan I. Ruiz, Maria E. Suarez‐Almazor   +4 more
wiley   +1 more source

Clinical Assessment and Cytomorphometric Analysis of Buccal Mucosal Cells in Behçet’s Disease Patients

Journal of Baghdad College of Dentistry, 2019
Background: Behçet’s disease (BD) is a disorder of systemic inflammatory condition. Its important features are represented by recurrent oral, genital ulcerations and eye lesions. Aims.
Dalya Mohammed, Layla S Yas
doaj   +1 more source